Squarepoint
KALA icon

Squarepoint’s KALA BIO KALA Stock Holding History

Squarepoint’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-6
Closed -$5K – 3206
2022
Q2 		$5K Buy
+6
New +$9.41K ﹤0.01% 2804
2021
Q2 		– Sell
-23
Closed -$383K – 3469
2021
Q1 		$383K Buy
23
+5
+28% +$97.6K ﹤0.01% 2227
2020
Q4 		$310K Sell
18
-16
-47% -$301K ﹤0.01% 2182
2020
Q3 		$639K Sell
34
-42
-55% -$965K 0.01% 1244
2020
Q2 		$1.98M Buy
+76
New +$2.15M 0.03% 634
2020
Q1 		– Sell
-4
Closed -$41K – 2191
2019
Q4 		$41K Buy
+4
New +$38.6K ﹤0.01% 2404
2019
Q3 		– Sell
-5
Closed -$80K – 2509
2019
Q2 		$80K Buy
+5
New +$82.8K ﹤0.01% 2249
2019
Q1 		– Sell
-11
Closed -$136K – 2291
2018
Q4 		$136K Buy
11
+1
+10% +$17.3K ﹤0.01% 1766
2018
Q3 		$245K Buy
+10
New +$305K ﹤0.01% 1650

Other funds holding KALA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Squarepoint's KALA Position: Q3 2022 in Review

Squarepoint sold out of KALA BIO (KALA) in Q3 2022, closing a stake of 6 shares — an estimated $5K sold.

Squarepoint first reported a position in KALA in Q3 2018 and held it in 9 quarters. The position peaked at $1.98M in Q2 2020. 53 funds tracked by Wall St. Rank hold KALA as of Q3 2022.

  • Squarepoint reported no remaining KALA BIO position as of Q3 2022 after selling out during the quarter.
  • Squarepoint sold 6 KALA BIO shares in Q3 2022, an estimated $5K.
  • Squarepoint first reported a position in KALA BIO in Q3 2018 and held it in 9 quarters.
  • Squarepoint's KALA BIO position peaked at $1.98M in Q2 2020.
  • 53 funds tracked by Wall St. Rank held KALA BIO as of Q3 2022.

Based on Squarepoint's 13F filing for Q3 2022, filed 14 Nov 2022.